Previous 10 | Next 10 |
2024-01-29 10:00:02 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Investors were most bullish on H...
Thinking about buying stock in Spectral AI, Applied UV, Adobe, BigBear.ai, or Aclarion? PR Newswire NEW YORK , Jan. 29, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MDAI, AUVI, ADBE, BBAI, and ACON. To see how Inves...
2024-01-29 08:22:54 ET Losers: Panbela Therapeutics PBLA -63% on $9M public offering . Aclarion ( ACON ) -19% . Corbus Pharmaceuticals Holdings ( CRBP ) -21% it releases data for ADC Tumor candidate . Richtech Robotics ( RR ) -11% . ...
2024-01-26 12:32:20 ET Gainers: Corbus Pharmaceuticals Holdings ( CRBP ) +300% . Aclarion ( ACON ) +66% . Panbela Therapeutics ( PBLA ) +36% . Inspire Veterinary Partners ( IVP ) +36% . Rail Vision Ltd ( RVSN ) +34% . Appfoli...
2024-01-26 08:32:05 ET Losers: Aclarion ( ACON ) 119% . Panbela Therapeutics ( PBLA ) 59% . Processa Pharmaceuticals ( PCSA ) 29% . Corbus Pharmaceuticals Holdings ( CRBP ) 23% . as targeting antibody drug conjugate demonstrates encouragin...
2024-01-26 08:21:02 ET Aclarion ( ACON ) +113% . Panbela Therapeutics ( PBLA ) +65% FORM S-1/A | Securities Registration Statement. TC BioPharm (Holdings) ( TCBP ) +17% . Ucommune International ( UK ) +17% . Processa Pharma...
2024-01-23 09:59:59 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Investors were most bullish on H...
2024-01-22 17:00:47 ET More on Aclarion, Inc. Financial information for Aclarion, Inc. Read the full article on Seeking Alpha For further details see: Aclarion files to sell 2.5M shares for its holder
Dr. Uribe is Chief of the Division of Spinal Disorders, Volker K. H. Sonntag Chair of Spine Research, and Vice Chairman of Neurosurgery at Barrow Neurological Institute Dr. Uribe Becomes Aclarion’s 3 rd KOL With Access to a Diagnostic Center Authorized to Perform Nociscans BROO...
Nociscan is the first augmented intelligence platform to measure pain biomarkers in the lumbar spine This new product release expands accessibility of Nociscan on the worldwide MR market Builds on preexisting compatibility with Siemens BROOMFIELD, CO, Jan. 17, 2024 (GLOBE NE...
News, Short Squeeze, Breakout and More Instantly...
Aviva is a Top 4 Provider of Private Medical Insurance in the UK By Joining AXA, Approximately 45% of Patients With Private Insurance Now Have Access to Nociscan in the Greater London Spine Care Market BROOMFIELD, CO, July 09, 2024 (GLOBE NEWSWIRE) -- Aclarion, Inc., (ȁ...
AXA is the 2 nd Largest Provider of Private Medical Insurance in the UK Payer Coverage is the Most Important Catalyst Aclarion can Achieve to Drive Volume and Revenue AXA Represents the First Insurance Company to Approve Payment for Nociscan BROOMFIELD, CO, June 26, 2024 (GLOBE NE...
Established in 1932, the London Clinic is the UK’s Most Renowned Independent, Private Hospital Payment to Aclarion for Each Nociscan is Being Increased From the Original Contract Contract Extension Aligns Aclarion and The London Clinic With Engaging Payers to Increase Acces...